Cost-Utility and Budget Impact Analysis of Adding SGLT-2 Inhibitors to Standard Treatment in Type 2 Diabetes Patients with Heart Failure: Utilizing National Database Insights from Thailand
External Link:
https://pubmed.ncbi.nlm.nih.gov/39306816/
Department of Clinical Epidemiology and Biostatistics
